K-numberK253512
Device nameMiniMed Go App
ApplicantMedtronic Minimed
Product codeNDC
Device classClass II
Decision dateJan 8, 2026
DecisionSubstantially Equivalent
Regulation868.1890
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The MiniMed Go App is a software-only mobile application that connects with compatible continuous glucose monitors (Simplera and Instinct sensors) and the InPen smart insulin injector to help people with diabetes manage their therapy. It provides data visualization, insulin dose calculation based on glucose values and carbohydrate intake, event logging, and alerts/reminders for glucose and insulin dosing.

Technological characteristics

Compared to the predicate InPen System App, the MiniMed Go App adds direct Bluetooth and NFC connectivity to compatible CGMs (Simplera and Instinct sensors) for real-time glucose display and trend arrows, whereas the predicate obtained glucose values from cloud servers. Both apps support the same insulin dose calculator functionality, therapy settings ranges (with minor differences in carb ratio and insulin sensitivity ranges), and alert types. The subject device also runs on a dedicated durable handheld medical device (App Manager) in addition to standard smartphones.

Test standards cited

Testing conducted per EN IEC 62304:2015 (software life cycle processes), IEC 62368-1 (electromagnetic compatibility), IEC 62366-1:2015 and HE75:2009 (human factors/usability), ISO 10993-1 (biocompatibility), ISO 14971:2019 (risk management), and FDA guidance on human factors engineering.

Substantial equivalence argument

The MiniMed Go App is substantially equivalent to the InPen System App (K242775) because both are Class II software devices with the same manufacturer, product code, regulation, and intended use for diabetes management via insulin dose calculation and logging. Although the subject device adds CGM connectivity and expanded patient populations, the core insulin dosing algorithm and therapeutic function remain unchanged, all technological differences were tested and shown not to raise safety concerns, and comprehensive performance validation demonstrates safe and effective operation.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →